PRESS-RELEASE ·Filed Nov 17, 2026
Press release · FDA
BIIB drugs
BIIB drug pipeline →Price Chart
Loading chart...
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3405221 |
Track record
35 reports on BIIB
10 of 12 bullish or bearish reports moved the stock their way by T+60. Best: +15.73% at T+60 after the Jul 13, 2026 report. 16 of 17 went positive at some point.
Filters
- Nov 17, 2026today Press Release Bullish 6/10 Viewing Entry $253.00 Now $250.79 −0.87% settles Feb 17
- Nov 12, 20264d ago Press Release Neutral 3/10 Entry $253.40 Now $250.79 −1.03% settles Feb 11
- Nov 10, 20267d ago SC 13G Neutral 3/10 Entry $253.25 Now $250.79 −0.97% settles Feb 8
- Nov 9, 20268d ago Press Release Neutral 4/10 Entry $254.87 Now $250.79 −1.60% settles Feb 5
- Oct 28, 202620d ago Institutional Cluster Neutral 2/10 Entry $244.05 Now $250.79 +2.76% settles Jan 26
- Oct 28, 202620d ago 8-K Bullish 6/10 Entry $244.05 Now $250.79 +2.76% settles Jan 26
- Oct 19, 202629d ago Press Release Neutral 4/10 Entry $233.48 Now $250.79 +7.41% settles Jan 14
- Oct 12, 20265w ago ANALYST-UPGRADE Bullish 6/10 Entry $229.41 Now $250.79 +9.32% settles Jan 7
- Oct 2, 20266w ago Press Release Bullish 6/10 Entry $219.88 Now $250.79 +14.06% settles Dec 29
- Sep 17, 20268w ago Press Release Bullish 5/10 Entry $215.50 Now $250.79 +16.38% settles Dec 14
Showing 10 of 35
US Market Status
Market Closed · Opens Wed (< 1m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers